 |
 |

Polymerase Chain Reaction Analysis of Immunoglobulin Gene Rearrangement in Cutaneous Lymphoid Hyperplasias
Anne Bouloc, MD;
Marie-Hélène Delfau-Larue, MD, PhD;
Bernard Lenormand, MD;
Farnaz Meunier, MD;
Janine Wechsler, MD;
Elisabeth Thomine, MD;
Jean Revuz, MD;
Jean-Pierre Farcet, MD;
Pascal Joly, MD, PhD;
Martine Bagot, MD, PhD;
for the French Study Group for Cutaneous Lymphomas
Arch Dermatol. 1999;135:168-172.
Background The differential diagnosis of cutaneous lymphoid hyperplasia and B-cell lymphoma may be difficult. Whether the detection of clonal immunoglobulin gene rearrangement in the cutaneous lesion is predictive of a malignant outcome remains controversial. We therefore studied cases of cutaneous lymphoid hyperplasia by polymerase chain reaction analysis.
Design Retrospective study of patients seen between 1988 and 1996.
Setting Two dermatology university departments.
Patients Twenty-four patients with cutaneous lymphoid hyperplasias were included according to clinical, histopathological, and immunophenotypic criteria.
Main Outcome Measures Clinical, histopathological, and laboratory findings.
Results There were 13 men and 11 women (mean age, 49 years) who presented with erythematous or violaceous papules or nodules. The lesions were unique in 13 cases and multiple in 11 cases. All patients had immunochemical evidence of a mixed T- and B-cell infiltrate with polytypic B cells. Polyclonality was demonstrated in 23 patients, whereas a dominant B-cell clone was detected in 1 patient. No lymphoma developed during the follow-up (median, 4 years). In the same period, we studied 53 cases of B-cell lymphomas. Thirty-five (66%) of the 53 cases had a detectable clonal immunoglobulin gene rearrangement.
Conclusions In the majority of our cases, polyclonality demonstrated by polymerase chain reaction analysis was in accordance with the diagnosis of cutaneous lymphoid hyperplasia. In 1 of the 24 patients, the presence of a B-cell clone could be evidenced. This fact did not modify the treatment as there were no histological or immunophenotypic signs suggestive of a lymphoma.
From the Departments of Dermatology (Drs Bouloc, Meunier, Revuz, Bagot), Immunobiology (Drs Delfau-Larue and Farcet), and Pathology (Dr Wechsler), Hospital Henri-Mondor, Créteil, France; and the Departments of Hematology (Dr Lenormand), Pathology (Dr Thomine), and Dermatology (Dr Joly), Hospital Charles Nicolle, Rouen, France.
RELATED ARTICLE
Archives of Dermatology Reader's Choice: Continuing Medical Education
Arch Dermatol. 1999;135(2):226-227.
FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Extranodal Marginal Zone B-Cell Lymphoma/Maltoma of the Lip in a Child: Case Report and Review of Cutaneous Lymphoid Proliferations in Childhood
Zambrano et al.
INT J SURG PATHOL 2006;14:163-169.
ABSTRACT
Detection of Clonally Restricted Immunoglobulin Heavy Chain Gene Rearrangements in Normal and Lesional Skin: Analysis of the B Cell Component of the Skin-Associated Lymphoid Tissue and Implications for the Molecular Diagnosis of Cutaneous B Cell Lymphomas
Nihal et al.
J. Mol. Diagn. 2000;2:5-10.
ABSTRACT
| FULL TEXT
PCR for Detecting Clonal Rearrangement
Journal Watch Dermatology 1999;1999:2-2.
FULL TEXT
|